Rapid clinical precision is transforming patient outcomes in South Bengaluru. As diagnostic technology evolves in 2026, QXL Diagnostics continues to lead with state-of-the-art automated immunoassay systems and multiplex real-time PCR molecular testing.
Key Clinical Innovations in 2026:#
- Sub-6-Hour Pathogen Molecular Panels: Rapid multiplex PCR testing for respiratory, gastrointestinal, and systemic tropical fever infections.
- High-Throughput Chemiluminescence (CLIA): Precision hormonal, vitamin D (25-OH), and cardiac marker quantification with sub-nanogram sensitivity.
- Daily Dual-Level Westgard IQC & EQAS Alignment: Every batch undergoes automated statistical quality control under ISO 15189:2022 standards.
Every report generated is reviewed and authorized by our senior team of consultant pathologists, clinical biochemists, and microbiologists.
Medical & Laboratory Disclaimer
This clinical article is published solely for patient education and informational purposes. It does not replace personal medical advice, clinical diagnosis, prenatal genetic counselling, or obstetric supervision. Appropriate laboratory investigations must be determined by your treating physician based on your personal health history.
Dr. Shantakumar Muruda, MD (Biochemistry)
Head of Clinical Biochemistry & Quality Management, QXL Diagnostics Bengaluru (NABL Accredited Laboratory MC-6849). Trained Lead Assessor for ISO 15189:2022 medical laboratory standards.
QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.
